Ana Margarida Vieira, Cláudia Cardoso, Élia Gamito, Ana Luísa Alves, Ana Paula Oliveira
Serviço de Gastrenterologia, Centro Hospitalar de Setúbal - Hospital de São Bernardo, EPE
RESUMO
INTRODUÇÃO: O envolvimento anal em doentes com Pênfigo Vulgar tem sido raramente reportado. Apresentamos o caso de uma doente de 76 anos com diagnóstico de Pênfigo Vulgar muco-cutâneo, sob corticoterapia sistémica, que inicia quadro proctológico caracterizado por hematoquézias e proctalgia associado a obstipação e dificuldade defecatória. A rectosigmoidoscopia flexível não mostrou alterações, mas o exame proctológico revelou coroa de mariscas com múltiplas erosões, compatível com Pênfigo Vulgar anal. Após corticoterapia local e normalização do trânsito intestinal, verificou-se cicatrização das lesões anais.
PALAVRAS-CHAVE: Pênfigo vulgar, pênfigo vulgar anal, envolvimento gastrointestinal no pênfigo vulgar.
]]> Pemphigus Vulgaris with Anal Involvement
ABSTRACT
INTRODUCTION: Anal involvement in patients with Pemphigus Vulgaris has rarely been reported. We report a case of a 76-year-old woman with muco-cutaneous Pemphigus Vulgaris on systemic corticotherapy who started with hematochezia and anal pain associated with constipation and difficult defecation. Flexible sigmoidoscopy was normal but proctologic examination revealed skin tags with multiple erosions. After local corticotherapy and normalization of bowel movements, healing of anal lesions was seen.
KEY-WORDS: Pemphigus vulgaris, anal pemphigus vulgaris, gastrointestinal involvment in pemphigus.
Texto completo disponível apenas em PDF.
Full text only available in PDF format.
REFERÊNCIAS
1. Heaphy MR, Albrecht J, Werth VP. Dapsone as a glucocorticoidsparing agent in maintenance-phase pemphigus vulgaris. Arch Dermatol 2005;141:699-702. [ Links ]
2. El-Darouti M, Marzouk S, Abdel Hay R, et al. The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study. Br J Dermatol 2009;161:313-319.
3. Mayrshofer F, Hertl M, Sinkgraven R, et al. Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous skin Disease (BSD) Study Group. J Dtsch Dermatol Ges 2005;3:431-435.
4. Mahajan VK, Sharma NL, Sharma RC, et al. Twelve-year clinicotherapeutic experience in pemphigus: A retrospective study of 54 cases. Int J Dermatol 2005;44:821-827.
5. Shahidi-Dadras M, Karami A, Toosy P, et al. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris. Arch Iran Med 2007;10:1-6.
6. Yeh SW, Sami N, Ahmed RA. Treatment of pemphigus vulgaris: current and emerging options. Am J Clin Dermatol 2005;6:327-342.
7. Kasuvi S, Daneshpazhooh M, Farahani F, et al. Outcome of pemphigus vulgaris. J Eur Acad Dermatol Venereol 2008;22:580-584.
8. Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol 2007;57:622-628.
9. Malik M, El Tal AE, Ahmed AR. Anal involvement in pemphigus vulgaris. Dis Colon Rectum 2006;49:500-506.
10. Shamim T, Varghese VI, Shameena PM, et al. Pemphigus vulgaris in oral cavity: clinical analysis of 71 cases. Med Oral Patol Oral Cir Bucal 2008;13:622-626.
11. Rao PN, Samarth A, Aurangabadkar SJ, et al. Study of upper gastrointestinal tract involvement in pemphigus by esophago-gastro-duodenoscopy. Indian J Dermatol Venereol Leprol 2006;72:421-424.
]]>Correspondência: Ana Margarida Duarte da Silva Vieira; Telemóvel: +351 961 704 152; Email: ana.amdsv@gmail.com.
Recebido para publicação: 29/09/2009 e Aceite para publicação: 24/09/2010.
]]>